• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Spherix Incorporated (SPEX) - Financial and Strategic SWOT Analysis Review - Product Image

Spherix Incorporated (SPEX) - Financial and Strategic SWOT Analysis Review

  • Published: May 2014
  • 38 pages
  • GlobalData

FEATURED COMPANIES

  • Eli Lilly and Company
  • ICF International, Inc.
  • Novo Nordisk A/S
  • Sanofi
  • Zaptronix Limited
  • MORE

Spherix Incorporated (SPEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – READ MORE >

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Spherix Incorporated - Key Facts
Spherix Incorporated - Key Employees
Spherix Incorporated - Major Products and Services
Spherix Incorporated - Pharmaceutical Pipeline Products Data
Spherix Incorporated, Pipeline Products by Therapy Area
Spherix Incorporated, Pipeline Products by Development Phase
Spherix Incorporated - History
Spherix Incorporated - Company Statement
Spherix Incorporated - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Spherix Incorporated - Business Description
Spherix Incorporated - SWOT Analysis
SWOT Analysis - Overview
Spherix Incorporated - Strengths
Strength - Patent Portfolio
Strength - Business Initiatives
Spherix Incorporated - Weaknesses
Weakness - History of Losses
Weakness - Legal Proceedings
Spherix Incorporated - Opportunities
Opportunity - Market for Diabetes
Opportunity - Rising Healthcare Expenditure in the US
Opportunity - IP Monetization industry
Spherix Incorporated - Threats
Threat - Competitive Pressures
Threat - Tightening of FDA’s Regulatory Oversight
Threat - Uncertain R&D Outcomes
Spherix Incorporated - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Spherix Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Spherix Incorporated, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Spherix Incorporated, Recent Deals Summary
Section 5 – Company’s Recent Developments
Spherix Incorporated, Recent Developments
Mar 17, 2014: Fortune 500 Executive Joins Spherix as Vice President, Licensing
Feb 12, 2014: Spherix Announces Litigation Update in Lawsuits Against VTech and Uniden
Jan 09, 2014: Spherix Appoints Richard Cohen as Chief Financial Officer
Jan 06, 2014: Spherix Acquires Over 100 Patents and Patent Applications Portfolio from Rockstar Consortium
Jul 10, 2013: Spherix Announces Results of Studies to Explore Sports and Nutrition/Nutraceutical Markets for D-tagatose
May 20, 2013: Spherix Reports Q1 2013 Results
Mar 20, 2013: Spherix Reports 2012 Results
Feb 28, 2013: Spherix Names Harvey Kesner As Interim CEO
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Spherix Incorporated, Key Facts
Spherix Incorporated, Key Employees
Spherix Incorporated, Major Products and Services
Spherix Incorporated, Number of Pipeline Products by Therapy Area
Spherix Incorporated, Number of Pipeline Products by Development Stage
Spherix Incorporated, Pipeline Products By Therapy Area and Development Phase
Spherix Incorporated, History
Spherix Incorporated, Subsidiaries
Spherix Incorporated, Key Competitors
Spherix Incorporated, Ratios based on current share price
Spherix Incorporated, Annual Ratios
Spherix Incorporated, Interim Ratios
Spherix Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Spherix Incorporated, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Spherix Incorporated, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Spherix Incorporated, Pipeline Products by Therapy Area
Spherix Incorporated, Pipeline Products by Development Phase
Spherix Incorporated, Performance Chart (2009 - 2013)
Spherix Incorporated, Ratio Charts
Spherix Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Spherix Incorporated, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014

Zaptronix Limited
Sanofi
Eli Lilly and Company
Novo Nordisk A/S
ICF International, Inc.

Note: Product cover images may vary from those shown

RELATED PRODUCTS